Brian L. Heiss

Insertion of MicroRNA Targets into the Flavivirus Genome Alters Its Highly Neurovirulent Phenotype

Brian L. Heiss, Olga A. Maximova, Alexander G. Pletnev · Journal of Virology · 2010 · 77 citations · Full text

Highly Neurovirulent Phenotype, Viral Replication, Genetics +21

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis

Jaleh Fallah, Jianjin Xu, Chana Weinstock et al. · Journal of Clinical Oncology · 2024 · 64 citations · Full text

MicroRNA Targeting of Neurotropic Flavivirus: Effective Control of Virus Escape and Reversion to Neurovirulent Phenotype

Brian L. Heiss, Olga A. Maximova, Dzung Thach et al. · Journal of Virology · 2012 · 59 citations · Full text

COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia

Garth W. Strohbehn, Brian L. Heiss, Sherin J. Rouhani et al. · Clinical Pharmacology & Therapeutics · 2020 · 58 citations · Full text

Inflammation, Clinical Immunology, Noncritical Covid‐19 Pneumonia +15

The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3′ non-coding region of the genome

Amber R. Engel, Alexander A. Rumyantsev, Olga A. Maximova et al. · Virology · 2010 · 44 citations

Neurobiology Of Disease, Neurogenomics, Neurovirology +11